Research is the lifeblood of the University and powers everything we do, from our innovative teaching methods to our impressive portfolio of spin-out companies.
The REF 2014 measured the quality of research being performed in UK Universities over the past seven years. The ratings are used to inform the selective distribution of public funds for research.
Southampton is ranked 11th in the UK based on the volume of its high quality research in the 2014 REF. Results show that 84 per cent of Southampton’s research activity is considered of internationally excellent or world-leading quality.
In the first major assessment of UK research since 2008, Southampton remains one of the leading universities across a wide range of subjects:
•We have the best music department in the UK
•We made the most powerful EEE (Electronics and Electrical Engineering) submission
•We are the most powerful university in General Engineering
•We are top 5 in Oceanography, Geology and Environmental Sciences; Health Sciences; History; Modern Languages; and Social Policy
Medicine made up 14% of the University’s return. We submitted an inclusive return with a high power index (85% of eligible staff in Clinical Medicine and 100% in Primary Care), and with a high proportion of early career researchers.
75% of our research in Medicine was rated as "world leading" or "internationally excellent" in the REF 2014. For the first time, the impact of the research was also assessed, and 94% of our research was rated as either 3 or 4*. This proves that we are translating our discoveries into real world benefits.
In Clinical Medicine:
•We are the 13th most powerful in the UK
•64% of outputs are internationally excellent or world leading
•Over 60% of our impact is world leading (4*+3*: 95%)
•We have an excellent research environment (4*+3*: 100%)
In Primary Care we are ranked 3rd for outputs (4*+3*: 86%)
University of Southampton’s results in Medicine, based upon an inclusive return of research-active staff, confirm the international excellence of the Faculty’s research programmes, with the majority of research impact judged as ‘outstanding’ in terms of reach and significance.
These results also show that we have created an environment that produces research of world-leading quality to deliver our strategy of focused basic discovery and early clinical translation; strong collaborations with the physical, health and social sciences; and driving innovation and enterprise to extend the impact of our discoveries.